Cancer treatment

Cancer treatment encompasses a wide array of therapeutic strategies aimed at controlling or eliminating cancerous cells within the body. These strategies include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgical interventions. Each treatment modality targets different aspects of cancer cell biology, such as cell division, DNA replication, or immune evasion. Research in cancer treatment focuses on improving the efficacy, specificity, and safety of these therapies to enhance patient outcomes and reduce side effects. At CymitQuimica, we provide a comprehensive range of compounds and reagents to support your research in developing innovative and effective cancer treatments.

20
- 50
- 100
- 200

products per page. 970 products on this category.

Product data	Purity	Price range	Estimated delivery
Palbociclib Impurity 26 REF: 4Z-P-196030CAS: 2458234-37-0	- - -	To inquire	Tue 04 Mar 25
Goserelin EP Impurity L Diacetate ((D-Leu7)-Goserelin Diacetate) REF: 4Z-PG-158CAS: 1926163-38-3	- - -	To inquire	Tue 04 Mar 25
Palbociclib Impurity 31 REF: 4Z-P-196035CAS: 571189-51-0	- - -	To inquire	Tue 04 Mar 25
Bestatin Impurity 4 HCl REF: 4Z-B-119033CAS: 17279-30-0	- - -	To inquire	Tue 04 Mar 25
Fulvestrant-3-Glucuronide Lithium Salt REF: 4Z-F-313CAS: 261506-27-8	- - -	To inquire	Tue 04 Mar 25
Fulvestrant EP Impurity B (Fulvestrant 9-Sulfone) REF: 4Z-F-316CAS: 98008-06-1	- - -	To inquire	Tue 04 Mar 25
Gimeracil Impurity 7 REF: 4Z-G-047009CAS: 1227600-22-7	- - -	To inquire	Tue 04 Mar 25
Olaparib Impurity 33 REF: 4Z-O-032038CAS: 763114-26-7	- - -	To inquire	Tue 04 Mar 25
Palbociclib Impurity 2 REF: 4Z-P-196003CAS: 2204863-06-7	- - -	To inquire	Tue 04 Mar 25
Folinic Acid Impurity 9 REF: 4Z-F-068020CAS: 442634-22-2	- - -	To inquire	Tue 04 Mar 25
Olaparib Impurity 2 REF: 4Z-O-032003	- - -	To inquire	Tue 04 Mar 25
Goserelin EP Impurity G ((D-His2)-Goserelin) REF: 4Z-PG-157CAS: 1926163-37-2	- - -	To inquire	Tue 04 Mar 25
Goserelin EP Impurity A Ditrifluoroacetate REF: 4Z-PG-153CAS: 1926163-39-4	- - -	To inquire	Tue 04 Mar 25
Lenvatinib N-Oxide REF: 4Z-L-124005CAS: 1788901-86-9	- - -	To inquire	Tue 04 Mar 25
Carfilzomib-d8 REF: 4Z-C-121002CAS: 1537187-53-3	- - -	To inquire	Tue 04 Mar 25
Olaparib-d4 REF: 4Z-O-032004CAS: 763113-22-0	- - -	To inquire	Tue 04 Mar 25
Lenvatinib Impurity 14 REF: 4Z-L-124018CAS: 417722-93-1	- - -	To inquire	Tue 04 Mar 25
Goserelin EP Impurity I Tritrifluoroacetate REF: 4Z-PG-1513	- - -	To inquire	Tue 04 Mar 25
Abiraterone Impurity 28 REF: 4Z-A-8278CAS: 114611-53-9	- - -	To inquire	Tue 04 Mar 25
Enzalutamide-d6 REF: 4Z-E-068013CAS: 1443331-94-9	- - -	To inquire	Tue 04 Mar 25

5mg		To inquire
10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

Cancer treatment

Palbociclib Impurity 26

Ref: 4Z-P-196030

Goserelin EP Impurity L Diacetate ((D-Leu7)-Goserelin Diacetate)

Ref: 4Z-PG-158

Palbociclib Impurity 31

Ref: 4Z-P-196035

Bestatin Impurity 4 HCl

Ref: 4Z-B-119033

Fulvestrant-3-Glucuronide Lithium Salt

Ref: 4Z-F-313

Fulvestrant EP Impurity B (Fulvestrant 9-Sulfone)

Ref: 4Z-F-316

Gimeracil Impurity 7

Ref: 4Z-G-047009

Olaparib Impurity 33

Ref: 4Z-O-032038

Palbociclib Impurity 2

Ref: 4Z-P-196003

Folinic Acid Impurity 9

Ref: 4Z-F-068020

Olaparib Impurity 2

Ref: 4Z-O-032003

Goserelin EP Impurity G ((D-His2)-Goserelin)

Ref: 4Z-PG-157

Goserelin EP Impurity A Ditrifluoroacetate

Ref: 4Z-PG-153

Lenvatinib N-Oxide

Ref: 4Z-L-124005

Carfilzomib-d8

Ref: 4Z-C-121002

Olaparib-d4

Ref: 4Z-O-032004

Lenvatinib Impurity 14

Ref: 4Z-L-124018

Goserelin EP Impurity I Tritrifluoroacetate

Ref: 4Z-PG-1513

Abiraterone Impurity 28

Ref: 4Z-A-8278

Enzalutamide-d6

Ref: 4Z-E-068013